Closed
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Sale
Calculated transaction value
$749.32K

Rothblatt Martine A Chairperson & CEO

Transaction date Sep 21, 2026
Public filing date Sep 22, 2026
Filing lag Filed 1 day later

UTHR daily price context

Close on/before transaction
$493.1 Sep 21, 2026
First close after public filing
$489.42 Sep 23, 2026
30-day return after filing
+19.49% Through Oct 22, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
1,520 shares @ $492.97
SEC ownership
Indirect
Transaction code
S
Form
4
Filing identifier
0001106578-26-000146
Filing cohort

Transactions in this filing

Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$5.82M
Buys / sales
0 / 5
Transactions reported in the same official filing
Issuer Transaction Traded Value
United Therapeutics Corp UTHR Exercise Sep 21, 2026 $1.12M
United Therapeutics Corp UTHR Current Sale Sep 21, 2026 $749.32K
United Therapeutics Corp UTHR Sale Sep 21, 2026 $1.32M
United Therapeutics Corp UTHR Sale Sep 21, 2026 $1.07M
United Therapeutics Corp UTHR Sale Sep 21, 2026 $1.13M
United Therapeutics Corp UTHR Sale Sep 21, 2026 $418.65K
United Therapeutics Corp UTHR Exercise Sep 21, 2026 $0